BMS which sells large hepatitis B treatment 'Baraclude' filed a patent infringement prohibition injunction against Daewoong
BMS which sells large hepatitis B treatment 'Baraclude' filed a patent infringement prohibition injunction against Daewoong, and it is said that BMS had filed a patent infringement prohibition lawsuit against other pharmaceutical companies which participated in patent invalidity proceedings.
Cur...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
